El Complejo Hospitalario Universitario de Vigo, conocido por el acrónimo CHUVI es una institución de salud pública establecida en 2004, dependiente del Servicio Gallego de Salud. Ofrece servicios sanitarios a la población de la ciudad de Vigo y también a la de los municipios de su área de influencia.

During the past decade, Complejo Hospitalario Universitario de Vigo conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 5 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 3 clinical trials were completed. i.e. 15.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complejo Hospitalario Universitario de Vigo" #1 sponsor was "Fundación GECP" with 7 trials, followed by "PETHEMA Foundation" with 7 trials sponsored, "MicroPort CRM" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla" with 3 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario Universitario de Vigo" #1 collaborator was "B.Braun Surgical SA" with 3 trials as a collaborator, "Abbott Medical Devices" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Hospital San Carlos, Madrid" with 2 trials as a collaborator and "Janssen-Cilag, S.A." with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario Universitario de Vigo" are "Multiple Myeloma" (5 trials), "Non Small Cell Lung Cancer" (5 trials), "Acute Lymphoblastic Leukemia" (3 trials), "Breast Cancer" (2 trials) and "Cardiac Arrhythmias" (2 trials). Many other conditions were trialed in "Complejo Hospitalario Universitario de Vigo" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario Universitario de Vigo" are "Drug" (35 trials), "Device" (9 trials), "Other" (5 trials), "Biological" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (6 trials), "Dexamethasone" (4 trials), "Prednisone" (4 trials), "Atezolizumab" (3 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario Universitario de Vigo" are 56 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Complejo Hospitalario Universitario de Vigo". undefined are not yet recruiting, 12 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Complejo Hospitalario Universitario de Vigo, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario Universitario de Vigo, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 3 trials that are defined as “Not Applicable".